| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/16/2006 | EP1689721A1 Aminopyrazole derivatives as gsk-3 inhibitors |
| 08/16/2006 | EP1689718A1 1-amino-isoquinoline derivatives for the treatment of diseases associated with inappropriate alk5 activity |
| 08/16/2006 | EP1689713A1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease |
| 08/16/2006 | EP1689704A2 Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 08/16/2006 | EP1689493A1 Calcitonin gene related peptide receptor antagonists |
| 08/16/2006 | EP1689447A2 Gene transfer for regulating smooth muscle tone |
| 08/16/2006 | EP1689420A1 Use of g-csf for treating ischemia |
| 08/16/2006 | EP1689413A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids |
| 08/16/2006 | EP1689401A1 Method for reducing pain |
| 08/16/2006 | EP1689399A1 A tetrahydroquinoline derivative for treating nicotine craving |
| 08/16/2006 | EP1689385A2 Neuroactive substance and uses of one such substance |
| 08/16/2006 | EP1689378A1 Novel use of peptide compounds for treating central neuropathic pain |
| 08/16/2006 | EP1689371A2 Pharmaceutical compositions of mirtazapine |
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1509241B1 Novel uses of cephaibols |
| 08/16/2006 | EP1432702B1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 08/16/2006 | EP1337247B1 Use of Gaboxadol for the treatment of premenstrual disorder, postnatal depression or postmenopausal related dysphoric disorder |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP1261603B1 Flavone derivatives, preparation method and use as medicines |
| 08/16/2006 | EP1183020B1 (3-trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin resistance and type 2 diabetes |
| 08/16/2006 | EP1171123B1 Method for treating neurodegeneration |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1117682B1 Chi-Conotoxin Peptides as INhibitors of Neuronal Amine Transporters |
| 08/16/2006 | EP1058726B1 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 08/16/2006 | EP1019075B9 Beta 2-adrenergic receptor agonists |
| 08/16/2006 | EP0980362B1 Substituted heterocycles and their use in medicaments |
| 08/16/2006 | EP0964677B1 Sustained analgesia achieved with transdermal delivery of buprenorphine |
| 08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/16/2006 | EP0527917B2 Use of adenosine and adenosine derivatives for anesthesia |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820003A Pyrrole-2, 5-dithione derivatives as liver X receptor modulators |
| 08/16/2006 | CN1819995A Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
| 08/16/2006 | CN1819846A Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist |
| 08/16/2006 | CN1819833A Hgf production accelerator containing heparin-like oligosaccharide |
| 08/16/2006 | CN1819828A Nasal pharmaceutical composition of piribedil |
| 08/16/2006 | CN1819827A Further therapeutic use of zolpidem |
| 08/16/2006 | CN1817884A Pyrimidinone derivatives and 3-keto ester |
| 08/16/2006 | CN1817883A New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound |
| 08/16/2006 | CN1817882A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/16/2006 | CN1817865A Preparation of sinomontanine and its hydrobromide |
| 08/16/2006 | CN1817854A Amino acids with affinity for the alpha-2-delta protein |
| 08/16/2006 | CN1817367A Activation and inhibition of the immune system |
| 08/16/2006 | CN1817358A Zhi Tengling by osmation |
| 08/16/2006 | CN1817351A Production of variolaria amra medicinal extract and its medicinal preparation |
| 08/16/2006 | CN1269955C Manufacture of hemoglobin-based oxygen carrier |
| 08/16/2006 | CN1269942C Hops extracts, method for prodn. and use |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269814C Process and intermediates for pyridazinone antidiabetic agents |
| 08/16/2006 | CN1269811C Piperazine derivatives having SST1 antagonistic activity |
| 08/16/2006 | CN1269805C 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269797C Crystalline form of a phenylethanolamine, preparation thereof and pharmaceutical compositions comprising same |
| 08/16/2006 | CN1269783C Hyperforin halogenated derivatives, the use thereof and formulations containing them |
| 08/16/2006 | CN1269523C Combined Chinese traditional medicine for strengthening immunity, anti virus, dispeling the effects of alcohol and preventing influenza and catch cold |
| 08/16/2006 | CN1269519C Capsule of activating the channels for cervical vertebrae |
| 08/16/2006 | CN1269500C Chinese traditional medicine for treating arthralgia due to wind-dampness and preparation method thereof |
| 08/16/2006 | CN1269482C Application of Na-ion channel blocker and opium antalgesic in preparing synergic antalgic medicine for mammal |
| 08/15/2006 | USRE39239 Methods for treating early morning pathologies |
| 08/15/2006 | US7091372 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
| 08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
| 08/15/2006 | US7091347 2-substituted amino-bicyclic pyridine and pyrimidine compounds; for treatment of inflammation, inflammatory bowel disease, Alzheimer's disease, Crohn's disease, multiple sclerosis and asthma |
| 08/15/2006 | US7091242 Beta-amino acid derivatives as integrin receptor antagonists |
| 08/15/2006 | US7091237 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 08/15/2006 | US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 08/15/2006 | US7091230 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091222 4-(1,2-Dimethyl-1H-imidazol-4-ylethynyl)-2-methyl-pyridine compounds; treating chronic neurological disorders |
| 08/15/2006 | US7091220 Substituted indole Mannich bases |
| 08/15/2006 | US7091218 4-indenone, n-benzyl substituted piperdine compounds; inhibiting acetylcholinesterase to treat Alzheimer-type senile dementia |
| 08/15/2006 | US7091216 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity |
| 08/15/2006 | US7091215 Corticotropin-Releasing Factor (CRF) receptor antagonist |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091212 Chiral dinapsoline |
| 08/15/2006 | US7091210 Substituted 2-aminoacetamides and the use thereof |
| 08/15/2006 | US7091208 Janus Kinase inhibitors and optionally mixed with antiinflammatory agents, for use as immunosuppresants for prophylaxis of lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes and graft versus host diseases |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091203 Imidazo[1,3,5]triazinones and their use |
| 08/15/2006 | US7091201 Arylalkane-sulfonamides having endothelin-antagonist activity |
| 08/15/2006 | US7091198 2,5-disubstituted pyrimidine derivatives |
| 08/15/2006 | US7091195 Derived from plants; for preventing or inhibiting tumor growth |
| 08/15/2006 | US7091182 Analyzing a blood sample for secretin level |
| 08/15/2006 | US7091176 Methods for treating arthritis pain |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7091006 Isolated nucleic acid of given sequence; use in identifying metabolic and neurological disorders |
| 08/15/2006 | US7090871 Composition containing pyrrolizidine-alkaloid-free petasites |
| 08/15/2006 | US7090864 Non-invasive gene targeting to ocular cells |
| 08/15/2006 | US7090835 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 08/15/2006 | CA2395231C Hydrogel-driven layered drug dosage form |
| 08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
| 08/15/2006 | CA2161783C Ampa antagonists and a method of treatment therewith |
| 08/10/2006 | WO2006084015A2 Raf inhibitor compounds and methods |
| 08/10/2006 | WO2006083795A1 Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia |
| 08/10/2006 | WO2006083760A1 AMINO-PYRIDINES AS INHIBITORS OF β-SECRETASE |
| 08/10/2006 | WO2006083711A1 Tachykinin receptor antagonists |
| 08/10/2006 | WO2006083673A2 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases |
| 08/10/2006 | WO2006083204A1 Antidepressant medicament comprising idazoxan and a selective serotonin reuptake inhibitor |
| 08/10/2006 | WO2006083042A1 Agent for prevention/treatment of neurodegenerative disease |